Caffeine clinical trials

Explore recruiting caffeine clinical trials.

Recruiting caffeine studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Caffeine trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Caffeine Administration for Preterms: Pharmacokinetics, Utilization and Correlation Inhibiting Nociception Outcome

Czechia

Therapeutic use (Phase IV) EU CTIS Study details

Multicentre, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Effect of a 30-week Caffeine Treatment on Cognition in Alzheimer's Disease at Beginning to Moderate Stages. Effect of CAFeine on Cognition in Alzheimer's Disease ( CAFCA )

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

The effect of additional pre-extubational loading dose of caffeine-citrate

Hungary

Therapeutic use (Phase IV) EU CTIS Study details

Evaluation of bioequivalence of two products containing 400 mg ibuprofen and 100 mg caffeine: Ibuprofen / Caffeine 400 mg / 100 mg coated granules (Test) vs. Thomapyrin TENSION DUO, 400mg / 100mg Filmtabletten (Reference). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy volunteers

Bulgaria

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Impact of epilepsy on the brainstem adenosine pathway and its relation with arousal and respiratory reactivity BRAVE

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A study to test whether BI 456906 (survodutide) influences the amount of bupropion, caffeine and midazolam in the blood in people with overweight or obesity

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

Caffeine trials by city

Caffeine in Toronto Caffeine in Vancouver Caffeine in Montreal Caffeine in Calgary Caffeine in Edmonton Caffeine in Ottawa Caffeine in Winnipeg Caffeine in Quebec City Caffeine in Hamilton Caffeine in Kitchener Caffeine in London Caffeine in Halifax Caffeine in New York Caffeine in Los Angeles Caffeine in Chicago Caffeine in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease